Inventor
LÖSCHER Frank
DE18 patents
⚠️ This page may combine multiple inventors who share the name “LÖSCHER Frank”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVALIQ GMBH
15 patentsUS11357738B2Jun 14, 2022
Semifluorinated compounds and their compositions
NOVALIQ GMBH15 citations93
US11273174B2Mar 15, 2022
Iodine compositions
NOVALIQ GMBH17 citations93
US11154513B2Oct 26, 2021
Semifluorinated compounds
NOVALIQ GMBH20 citations93
US10682315B2Jun 16, 2020
Semifluorinated compounds and their compositions
NOVALIQ GMBH21 citations93
US10813976B2Oct 27, 2020
Ophthalmic compositions comprising ciclosporin
NOVALIQ GMBH20 citations92
US12128010B2Oct 29, 2024
Semifluorinated compounds and their compositions
NOVALIQ GMBH6 citations85
US11723861B2Aug 15, 2023
Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
NOVALIQ GMBH7 citations84
US11896559B2Feb 13, 2024
Opthalmic compositions comprising F6H8
NOVALIQ GMBH7 citations83
US11400132B2Aug 2, 2022
Ophthalmic compositions comprising ciclosporin
NOVALIQ GMBH8 citations83
US12226422B2Feb 18, 2025
Ophthalmic compositions comprising tafluprost for the treatment of glaucoma
NOVALIQ GMBH6 citations81
US11576893B2Feb 14, 2023
Pharmaceutical compositions comprising nebivolol
NOVALIQ GMBH7 citations81
US11684589B2Jun 27, 2023
Pharmaceutical compositions for use in the therapy of blepharitis
NOVALIQ GMBH6 citations73
US12569452B2Mar 10, 2026
Ophthalmic compositions comprising F6H8
NOVALIQ GMBH0 citations59
US12496326B2Dec 16, 2025
Ophthalmic composition for treatment of dry eye disease
NOVALIQ GMBH0 citations58
US12419933B2Sep 23, 2025
Ophthalmic composition for the treatment of uveitis
NOVALIQ GMBH0 citations57